As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...

In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative is emerging from the shadows ...

A new study has proven that Ozempic, used for both diabetes and weight loss, can also curb the desire to drink alcohol among ...

Share on PinterestScientists have found a link between certain eye conditions and GLP-1 medications. BONNINSTUDIO/Stocksy Past studies have found a potential link between semaglutide and the eye ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...